Short term infusion of glycine-extended gastrin17 stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa

International Journal of Cancer

Volumn 94, Issue 3, 2001, Pages 307-313

  Aly, Ahmad ^a   Shulkes, Arthur ^a   Baldwin, Graham S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aberrant crypt foci; Colorectal carcinoma; Gastrin17gly; Ozoxymethane; Proliferation

Indexed keywords

AZOXYMETHANE; GASTRIN 17; GLYCINE EXTENDED GASTRIN 17; GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CELL PROLIFERATION; CELL STIMULATION; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DESCENDING COLON; MALE; METAPHASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AZOXYMETHANE; CARCINOGENS; CELL DIVISION; COLON; COLONIC NEOPLASMS; GASTRINS; GLYCINE; HORMONES; MALE; MUCOUS MEMBRANE; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0035501607     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1483     Document Type: Article

References (49)

1. Gastric endocrine cells: Gene expression, processing and targeting of active products
2. Growth-promoting effects of glycine-extended progastrin
3. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells
4. Glycine-extended gastrin acts as an autocrine growth factor in a non-transformed colon cell line
5. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells
6. JMV 1155: A novel inhibitor of glycine-extended progastrin- mediated growth of a human colon cancer in vivo
7. Processing and proliferative effects of human progastrin in transgenic mice
8. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation
9. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM
10. -/+ mice
11. The role of gastrin in the adenoma: Carcinoma sequence in the colon
12. Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats
13. Intravenous but not intracolonic epidermal growth factor maintains colonocyte proliferation in defunctioned rat colorectum
14. Aberrant crypts: Potential preneoplastic lesions in the murine colon
15. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane
16. Diurnal variation in proliferative compartments and their relation to cryptogenic cells in the mouse colon
17. Expression, processing and secretion of gastrin in patients with colorectal carcinoma
18. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin
19. Glycine-extended gastrin regulates HEK cell growth
20. Developmental expression of the gastrin and cholecystokinin genes in rat colon
21. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings
22. Selektiv erzeugung von darmkrebs bei ratten durch 1,2-dimethlyhydrazin
23. Specificity study to evaluate induction of aberrant crypts in murine colons
24. Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine-induced colonic carcinogenesis
25. Hypergastrinemia in rats with azoxymethane-induced colon cancers
26. Inhibitory effect of a gastrin receptor antagonist, CR 2495, on 1,2-dimethylhydrazine-induced colorectal cancer in mice
27. Effects of gastrointestinal peptides on azoxymethane-treated colonic mucosa in vitro
28. Drug-induced hypergastrinemia: Absence of trophic effects on colonic carcinoma in rats
29. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen
30. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: Relationship to growth factor expression
31. Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane
32. Insulin injections promote the growth of aberrant crypt foci in the colon of rats
33. Controlled release of TGF-beta1 impedes rat colon carcinogenesis in vivo
34. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon
35. Sulindac and indomethacin inhibit the formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats
36. Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa
37. Cancer risk following pernicious anemia
38. Risk for colorectal adenocarcinoma in pernicious anemia: A population based cohort study
39. Rectal cell proliferation and colon cancer risk in patients with hypergastrinemia
40. Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy?
41. Gastrin as a growth factor in the gastrointestinal tract
42. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas
43. Gastin and gastrin receptor activation and early event in the adenoma-carcinoma sequence
44. Gastrin, gastrin receptors and colorectal carcinoma
45. Role of circulating gastrin in colorectal adenomas and carcinomas
46. Expression of progastrin derived peptides and gastrin receptors in a panel of gastrointestinal carcinoma cell lines
47. Incomplete processing of progastrin expressed by human colon cancer cells: Role of noncarboxyamidated gastrins
48. Expression but incomplete maturation of progastrin in colorectal carcinomas